Key takeaways A true generic version of Ozempic wont be available until at least 2033, as the drug is still under patent protection
For most people, it will take a period of up to 12 weeks to see results using AOD 9604
Moreover, in light of the growing evidence demonstrating the benefits of incretin-based therapies on both metabolic health and cardiovascular diseases, regulatory agencies such as the Food Drug Administration (FDA) and the European Medicines Agency (EMA) have approved their use for type 2 diabetes, reduction of cardiovascular risk and for chronic weight management in patients with morbid obesity [5,6,7,8]
This allows for significantly higher weight loss with a more favorable gastrointestinal profile (less severe nausea) than high-dose Semaglutide monotherapy
Safety & Medical Concerns Vital Step is a telehealth medical service
Semaglutide binds to GLP-1 receptors in multiple tissues throughout the body, including the pancreas, gastrointestinal tract, and brain
